rheumatoid arthritis
A Difficult Act—Balancing Heart Health and Treating RA
Guidelines from the American College of Rheumatology recommend that clinicians treating rheumatoid arthritis with ...
FEBRUARY 9, 2025
Taking the RA Threat to Heart During Pregnancy
Obesity, gestational diabetes mellitus and acute cardiovascular complications are more common among pregnant women ...
NOVEMBER 20, 2024
FDA Approves Citrate-Free Formulation of Hyrimoz, a Biosimilar to Humira
The FDA approved a citrate-free high-concentration formulation of Hyrimoz injection, a biosimilar to Humira.
MARCH 21, 2023
COVID-19 Vaccine Guidelines Address Special Considerations for Rheumatology Patients
The American College of Rheumatology (ACR) recently released recommendations for vaccinating rheumatology patients ...
JUNE 23, 2021
FDA Warns of Possible Serious CV Events, Cancer Linked to Xeljanz
The FDA issued an alert concerning an increased risk for serious cardiovascular events and malignancies with the ...
FEBRUARY 5, 2021
FDA Approves Abrilada, Biosimilar to Humira
This approval marks the 25th biosimilar approved in the United States, but only a handful are currently available. ...
NOVEMBER 19, 2019
FDA Approves Rinvoq for Moderate to Severe RA
The FDA approved Rinvoq, a 15-mg, once-daily oral JAK inhibitor, for the treatment of certain adults with ...
AUGUST 27, 2019
FDA Approves Hadlima Biosimilar for RA, Other Inflammatory Condition
Hadlima was approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic ...
AUGUST 27, 2019
ACR Issues Guide on Navigating Biosimilar Market
To help prescribers and pharmacists better navigate the use of biosimilars, the American College of Rheumatology ...
MARCH 2, 2018
Ixifi, a Biosimilar for RA, Receives Approval
FDA approves another biosimilar for Remicade. Ixifi has all of the same indications.
DECEMBER 14, 2017
Plivensia Rejected by FDA to Treat Rheumatoid Arthritis
The FDA Arthritis Advisory Committee has voted to deny the Biologics License Application approval of Johnson & ...
AUGUST 11, 2017
When to Stop, Start Meds for Rheumatic Patients Undergoing Hip and Knee Replacements
Periprosthetic joint infections are associated with high morbidity and mortality; perioperative management ...
JUNE 30, 2017
